To identify epigenetic factors mediating sensitivity to BET inhibition, an shRNA library targeting 626 chromatin regulators (2917 shRNAs) was screened in a mouse MLL-r AML cell model treated with JQ1 [37,64]. The gene discussed is KMT2A; the disease is acute myeloid leukemia.